IndraLab
Statements
reach
"Remarkably, PKCalpha knockdown also upregulated basal AKT activity in HEC-6 and SNG-M cells, two PTEN mutant cell lines that naturally harbor coincident mutations in the catalytic (PIK3CA) or regulatory (PIK3R1) subunits of PI3K, respectively (XREF_FIG, middle and right panels; also see XREF_FIG, compare lane 1 with lanes 3-6 in both panels)."
sparser
"PKCα-induced AKT inactivation may involve direct effects of PP2A family phosphatases on activating phosphorylation at T308 and S473 ( xref ), although potential effects on upstream regulators of AKT activity remain to be formally excluded ( xref ). (It should be noted that although PP2A may preferentially dephosphorylate AKT on the T308 site, it can also dephosphorylate AKT on the S473 site, as described in a variety of biological systems [ xref ].) A role of PP2A in the antitumor effects of PKCα in the endometrium is consistent with known functions of the phosphatase as a bona fide tumor suppressor, with key activities in maintenance of cellular homeostasis ( xref )."
reach
"These findings, together with the demonstration that agonist induced PKCalpha activation suppresses AKT in EC cells, identify PKCalpha as an inhibitor of PI3K and AKT signaling in the endometrium that is capable of disabling the AKT oncoprotein, even in the context of multiple activating mutations in upstream signaling intermediates (e.g., PTEN and PIK3CA in HEC-251 cells and PTEN, PIK3CA, and KRAS in SNG-M cells)."